Alby Elias
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Psychiatry and Mental health top 10%
- Co-authors
- K H AntmanDeborah Witt ShermanHolcombe E. GrierLouise RyanKaren H. AntmanLowell E. SchnipperE FreiW. David Henner
- Topics
- Electroconvulsive Therapy Studies (7 papers)Cancer Treatment and Pharmacology (6 papers)HER2/EGFR in Cancer Research (5 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Alby Elias
38 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Oncology 522
- Pulmonary and Respiratory Medicine 350
- Molecular Biology 213
- Pathology and Forensic Medicine 205
- Psychiatry and Mental health 133
Countries citing papers authored by Alby Elias
This map shows the geographic impact of Alby Elias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alby Elias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alby Elias more than expected).
Fields of papers citing papers by Alby Elias
This network shows the impact of papers produced by Alby Elias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alby Elias. The network helps show where Alby Elias may publish in the future.
Co-authorship network of co-authors of Alby Elias
This figure shows the co-authorship network connecting the top 25 collaborators of Alby Elias. A scholar is included among the top collaborators of Alby Elias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alby Elias. Alby Elias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 30 | |
| 4 | 13 | |
| 5 | 12 | |
| 6 | 7 | |
| 7 | 14 | |
| 8 | 10 | |
| 9 | 72 | |
| 10 | 13 | |
| 11 | 48 | |
| 12 | Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. | 4 |
| 13 | 99 | |
| 14 | 18 | |
| 15 | Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens. | 29 |
| 16 | High-dose thiotepa alone and in combination regimens with bone marrow support. | 30 |
| 17 | 155 | |
| 18 | 201 | |
| 19 | 3 | |
| 20 | Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study. | 20 |
About Alby Elias
Alby Elias is a scholar working on Psychiatry and Mental health, Critical Care and Intensive Care Medicine and Oncology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Electroconvulsive Therapy Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (522 citations), Pathology and Forensic Medicine (205 citations) and Hematology (123 citations). Alby Elias has collaborated with scholars based in United States, Australia and France. Frequent co-authors include K H Antman, Deborah Witt Sherman, Holcombe E. Grier, Louise Ryan, Karen H. Antman, Lowell E. Schnipper, E Frei, W. David Henner, Lois Ayash and Thomas C. Shea. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Psychiatry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.